accountinvestors won't care much what value was put on daclizumab and the rest of the pipeline. Like Eli Lilly's (NYSE: LLY) Have thoughts on which biotech will be the next to be taken out? Let us know in the comment box below...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to You Paid How Much for That?
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account